Why Medi-Span?
In recent surveys, successful healthcare companies described their experiences with Medi-Span and detailed the value of its data:
Satisfaction
98%of customers are satisfied with the quality of Medi-Span data
Renewal Rate
99%of customers are likely to renew their Medi-Span data license
Productivity
50%or greater increase in productivity reported by hundreds of Medi-Span customers
Wolters Kluwer brings you Medi-Span drug data, used across the healthcare continuum to help inform medication-related decisions.
Why do prominent healthcare companies prefer Medi-Span?
The sheer amount of data required to support healthcare decisions is impossible for one person, or even one organization, to wrangle. That’s why we streamline valuable content and decision support functionality into intelligent databases and integrated tools.
GPI
The Medi-Span GPI is a unique concept with a long-proven track record to identify drug products by a hierarchical therapeutic classification system. The 14-character hierarchy gives you power and flexibility that no static number could offer.
“Our business is built around the GPI. Having dependable and easily loadable data is a great help.” – Product lead from a large healthcare technology company
“Our business is built around the GPI. Having dependable and easily loadable data is a great help.” – Product lead from a large healthcare technology company
Content and editorial processes
Medi-Span data is powered by the expertise of an unrivaled, multidisciplinary editorial team, including advanced-degree pharmacists with expertise in various specialties, physicians, and informaticists, to deliver best-practice recommendations from current medical and pharmaceutical literature. As part of our editorial process, Medi-Span reviews multiple resources to develop clinically appropriate content and data resources based on the latest evidence available.
Optimized alerts
Along with expert data, Medi-Span also provides an intelligent console that allows for sophisticated alert management functionality to customize alerts by taking into account your patient’s clinical context and your users’ requirements.
Pricing leader
As one of the few sources for embedded AWP data available in the marketplace, we have the pricing benchmarks that top industry players use to help them remain competitive, analyze the market, and stay on top of new trends. Medi-Span has long-standing relationships with pharmaceutical manufacturers that allow us to deliver new and updated price information with unmatched speed. At the same time, our pricing benchmark data is published independently under our proprietary editorial policies that are intended to keep the information as unbiased as possible.
“It is the source for the benchmark prices consistently used in the PBM industry and the tool we use to hold PBMs accountable to their pricing promises to our employers.” – Insurance company senior actuarial consultant
“It is the source for the benchmark prices consistently used in the PBM industry and the tool we use to hold PBMs accountable to their pricing promises to our employers.” – Insurance company senior actuarial consultant
Harmonized drug decision support
With the move to team-based care, conflicting data can lead to actual conflicts—from disparity in business decisions to confusion in communication. Our professionals synthesize and organize content obtained from various sources so that it is available for the right people at the right time. When you use our drug information solutions across your organization—whether building your system, accessing reference content during dispensing, or sharing patient education materials—everyone is getting information designed to be complementary and developed using aligned methods. That helps lessen confusion and improve communication.
Global presence
Trusted by 180+ leading hospitals worldwide, Medi-Span offers multinational drug information that synthesizes a global perspective of medication utilization and safety. We value and incorporate clinical knowledge and feedback from our worldwide clinician partner network to help develop drug data solutions that reflect global best practices and important dosage and practice distinctions from various variations. Find out more about our work outside of the US and Canada.
Drug data is available with various delivery options to best meet your needs
Flat files
If you would like to see and manipulate the data for analysis purposes and have the infrastructure in place, we offer content as flat files.
APIs
If you are looking to implement faster with lesser development effort and resources, we offer locally hosted application programming interfaces (APIs).
Web services
If you are looking for embedded drug data in a cloud-based environment and need real-time data, we offer web services.
Top 5 reasons professionals prefer Medi-Span
Medi-Span has been the drug data choice of healthcare businesses and professionals for decades. Find out why.
Trusted drug data
You can have confidence in our data because it is the No. 1 choice of many leading companies.
Who prefers and trusts Medi-Span?
Payers
17 out of 20 of the top-grossing PBMs and 95% of the 20 top health insurance companies
EMRs
7 of the 10 top-grossing EMRs
Retail pharmacies
4 of the 5 top-grossing retailers
-
Speed to market
-
Competitive advantage
-
Valuable resource
-
Fast results
-
Consistent pricing data
-
Business essential
-
Key content
-
Provides confidence
-
Unifying data
-
Timely and relevant
-
Strong foundation
Medi-Span implementation support helped save me one month in speed to market and about $10,000 in development costs.
[Medi-Span] allows us to provide features that our competitors do not have.
As a claims processor, we rely on Medi-Span and its wealth of drug information to forecast and price claims for our clients. Medi-Span is the go-to [data resource] that is recognized across the industry for [manufacturer-provided] drug information. They have innovative tools and excellent customer service that will go above and beyond to provide the best available solution.
Medi-Span, in my view, beats everyone else. It helps you find twice as many drug errors—errors that would lead to readmission—in half the amount of time.
It is the source for the benchmark prices consistently used in the PBM industry and the tool we use to hold PBMs accountable to their pricing promises to our employers.
Business cannot survive without Medi-Span data.
Only reliable published resource for [manufacturer-provided] AWP. [Medi-Span proprietary] GPI is therapeutic classification system of choice. It is very enabling, as clinical management rules are easily articulated.
Even in an era where data abounds, there is a terrific amount of uncertainty. People want confidence that what they are seeing is [based on] real [manufacturer-provided information]—Medi-Span provides that confidence.
[Medi-Span] allows for consistency across the company, industry and clients.
The Medi-Span database allows our system to have the latest and most current information available. It is especially needed for package information, interaction checking, and clinical printing.
This is a foundational piece that is used throughout the organization in many systems and is often used to connect data from multiple systems.